Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Italians ban shock treatment:

This article was originally published in Clinica

Executive Summary

The Italian region, Piedmont, has banned the use of treatment (ECT) in children, the elderly and pregnant women. This treatment is highly controversial as it involves sending up to 460 volts of electricity through the brain to produce an epileptic fit and has been opposed by the international psychiatric watchdog group, the Citizens Commission on Human Rights. Piedmont has also said that where ECT is used, the psychiatrist in charge must adhere to strict guidelines, including supplying both in writing and verbally the possible harmful effects of the treatment. In the US, more than 100,000 patients undergo ECT each year, including the elderly, children and pregnant women.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT073062

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel